1, anticancer drugs:
Docetaxel, adriamycin, aloe, paclitaxel, oxaliplatin, etoposide, lysine platinum, tenoamide, irinotecan, teGrelleaud, imatinib, gemcitabine, temustine, telmisartan, pemetrexed.
2, anti-infective drugs:
Cefaclor, cefazolin, cefalexin, ceftriaxone, cefmetazole, cefamide, azithromycin, lamivudine, linezolid, tinidazole, amikacin, tilmicosin, chloramphenicol, amoxicillin, sulfamethoxazole, streptomycin, ciprofloxacin, roxithromycin, meropenem, penicillin, penicillin G, piperacillin and cytarabine.
Linezolid, mifepristone, hydroxychloroquine, amitriptyline, moxifloxacin, imidazolinone, piperacillin, terbutaline, misoprostol, amikacin, triamcinolone, cefazolin, cefalexin, ceftriaxone, cefmetazole and cefamide.
3. Anti-cardiovascular drugs:
Clopidogrel, lovastatin, acarbose, metoprolol, nifedipine, nitroglycerin, gliclazide, sunitinib besylate, telmisartan, phenytoin sodium, metoprolol, sitagliptin, carbamazepine, lidocaine, aspirin, vitamin K2, metoprolol, atenolol, lovastatin, batemi and tacrolimus.
Medical insurance use
Medical insurance refers to the basic medical insurance drugs, and the specific scope is managed by formulating the basic medical insurance drug list.
The principle of determining the drug list is to adhere to the drugs that are clinically necessary, safe and effective, reasonable in price, convenient to use, guaranteed in the market and affordable by medical insurance, based on the national basic medical insurance drug list. At the same time, we should not only consider the basic needs of clinical treatment, but also consider the economic differences and medication habits between regions, and pay equal attention to Chinese and Western medicine.